ArticleFrontiers in oncology2025
Mortality from sepsis among middle-aged and elderly patients with pancreatic cancer: CDC WONDER 1999 To 2023.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sepsis-related mortality in middle-aged and older pancreatic cancer patients constitutes a significant public health issue. This study seeks to analyze trends in the age-adjusted mortality rate (AAMR) for sepsis-related fatalities among these patients in the United States from 1999 to 2023, employing data from the most recent CDC WONDER database. The temporal patterns revealed from this analysis are anticipated to guide subsequent research and public health initiatives. Methods: The CDC WONDER database was used to look at how many middle-aged and older pancreatic cancer patients in the U.S. died from sepsis between 1999 and 2023. The study utilized AAMR to evaluate temporal mortality patterns among adults aged 45 and older, categorized by race, census region, urban/rural residency, and state, using the Joinpoint regression tool. We calculated the annual percent change (APC) and the average annual percent change (AAPC), and we supplied 95% confidence intervals. Results: During the study period, the sepsis-related death rate among middle-aged and elderly pancreatic cancer patients exhibited a notable increase, with an AAPC of 2.89. Male patients consistently demonstrated a greater AAMR compared to females, with a notable increase recorded [AAPC = 2.73 (95% CI 1.61 to 3.87)]. Black or African American patients had the greatest AAMR, which also went up a lot [AAPC = 2.62 (95% CI 1.76 to 3.48)]. The mortality burden increased significantly with age, reaching its highest point in the 75-84 age range. A regional study found that the Midwest had the highest rise in AAMR [AAPC = 3.74 (95% CI 2.50 to 5.00)]. Urban people consistently exhibited a higher AAMR compared to rural communities, despite the most significant increase in AAMR occurring among rural populations [AAPC = 3.51 (95% CI 2.09 to 4.94)]. Conclusion: This study's findings reveal substantial inequalities among gender, ethnicity, age, and geographic regions. These differences show how important it is to quickly implement targeted measures to lower mortality, especially among individuals at high risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.